What is Melodiol Global Health Earnings Yield (Joel Greenblatt) %?
Melodiol Global Health's Enterprise Value for the quarter that ended in Dec. 2023 was $11.19 Mil.
Melodiol Global Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-17.33 Mil. Melodiol Global Health's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was -140.85%.
The historical rank and industry rank for Melodiol Global Health's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
COPHF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -390.58 Med: -55.64 Max: -11.45
Current: -212.77
During the past 8 years, the highest Earnings Yield (Joel Greenblatt) of Melodiol Global Health was -11.45%. The lowest was -390.58%. And the median was -55.64%.
COPHF's Earnings Yield (Joel Greenblatt) % is ranked worse than 97.34% of 1092
companies
in the Drug Manufacturers industry
Industry Median: 2.33
vs COPHF: -212.77
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Melodiol Global Health's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Melodiol Global Health Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for Melodiol Global Health's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Melodiol Global Health Earnings Yield (Joel Greenblatt) % Chart
Competitive Comparison of Melodiol Global Health's Earnings Yield (Joel Greenblatt) %
For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Melodiol Global Health's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Melodiol Global Health's Earnings Yield (Joel Greenblatt) % falls into.
Melodiol Global Health Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Melodiol Global Healths Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
Melodiol Global Health (OTCPK:COPHF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Melodiol Global Health Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of Melodiol Global Health's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Melodiol Global Health (Melodiol Global Health) Business Description
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.
Melodiol Global Health (Melodiol Global Health) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COPHF has been successfully added to your 